Sign in

CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company

CERENOME, INC.

Sign in to watch
Ticker
CNSY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330827593
Phone
737.255.7194
Business address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
  1. 4 Grant or award Chief Executive Officer acquired 50,250 shares (grant or award)
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 6,000 shares (grant or award)
  11. 4 Grant or award Director acquired 6,000 shares (grant or award)
  12. 4 Grant or award Director acquired 6,000 shares (grant or award)
  13. 4 Grant or award Director acquired 6,000 shares (grant or award)
  14. 4 Grant or award Director acquired 6,000 shares (grant or award)
  15. 4 Open-market sale Chief Executive Officer sold 48,125 shares at an average $5.69 ($273,909)
  16. 8-K Event Material agreement · Unregistered share sale
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 8-K Event Executive or director change
  20. 4 Grant or award Director acquired 21,000 shares (grant or award)

Page 51 of 74 · 1,465 filings